Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank57
3Y CAGR-24.7%
5Y CAGR-18.7%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-24.7%/yr
vs +80.2%/yr prior
5Y CAGR
-18.7%/yr
Recent deceleration
Acceleration
-104.9pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $45.39M | -45.3% |
| 2024 | $82.95M | +18.9% |
| 2023 | $69.74M | -34.4% |
| 2022 | $106.34M | -24.3% |
| 2021 | $140.42M | +9.6% |
| 2020 | $128.16M | +1652.9% |
| 2019 | $7.31M | -27.5% |
| 2018 | $10.08M | +55.0% |
| 2017 | $6.51M | -67.1% |
| 2016 | $19.77M | - |